hexadecanesulfonyl fluoride and anandamide

hexadecanesulfonyl fluoride has been researched along with anandamide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavatte, P; Leleu-Chavain, N; Millet, R; Sansook, S; Spencer, J; Tuo, W1
Arreaza, G; Deutsch, DG; Hill, WA; Lin, S; Makriyannis, A; Morse, KL; Omeir, RL; Salehani, D1
Bruneus, M; Gatley, SJ; Gifford, AN; Goutopoulos, A; Lin, S; Makriyannis, A; Volkow, ND1
Rice, AS1
Aberman, JE; Arizzi, MN; Betz, A; Cervone, KM; Lin, S; Liu, Q; Makriyannis, A; Salamone, JD1
Bahr, BA; Karanian, DA; Karim, SL; Lin, S; Makriyannis, A; Williams, JS; Wood, JT1

Reviews

2 review(s) available for hexadecanesulfonyl fluoride and anandamide

ArticleYear
Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
    Journal of medicinal chemistry, 2017, 01-12, Volume: 60, Issue:1

    Topics: Amidohydrolases; Animals; Enzyme Inhibitors; Humans; Monoacylglycerol Lipases

2017
Cannabinoids and pain.
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:3

    Topics: Amides; Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Benzoxazines; Brain; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Membrane; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Drug Interactions; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Glycerides; Humans; Injections, Spinal; Molecular Structure; Morpholines; Naphthalenes; Pain; Palmitates; Palmitic Acids; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Spinal Cord

2001

Other Studies

4 other study(ies) available for hexadecanesulfonyl fluoride and anandamide

ArticleYear
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Biochemical and biophysical research communications, 1997, Feb-03, Volume: 231, Issue:1

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoids; Endocannabinoids; Enzyme Inhibitors; Fatty Acids; Neurons; Palmitates; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Sulfones; Tumor Cells, Cultured

1997
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374).
    European journal of pharmacology, 1999, Oct-21, Volume: 383, Issue:1

    Topics: Acetylcholine; Amidohydrolases; Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cyclohexanols; Drug Synergism; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Hippocampus; In Vitro Techniques; Male; Morpholines; Naphthalenes; Palmitates; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug

1999
Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide.
    Life sciences, 2004, Jan-09, Volume: 74, Issue:8

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoids; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Intraventricular; Male; Palmitates; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reinforcement Schedule

2004
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:3

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Endocannabinoids; Hippocampus; Kainic Acid; MAP Kinase Signaling System; Neuroprotective Agents; Palmitates; Polyunsaturated Alkamides; Rats; Seizures

2007